Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.21.73 extracted from

  • Lee, K.H.; Choi, E.Y.; Hyun, M.S.; Eun, J.R.; Jang, B.I.; Kim, T.N.; Lee, H.J.; Lee, D.S.; Yun, S.S.; Kim, H.J.; Kim, J.H.; Kim, J.R.
    Cellular mechanisms of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MAPK signaling in hepatocellular carcinoma (2008), Tumori, 94, 523-530.
    View publication on PubMed

Activating Compound

Activating Compound Comment Organism Structure
SB 203580 pretreatment of Hep-G2 cells with SB 203580 increases hepatocyte growth factor-mediated uPA secretion by 50-60% Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
additional information stable expression of dominant-negative MEK-1 in Hep-G2 cells decreases S hepatocyte growth factor-mediated uPA secretion Homo sapiens
PD 098059 hepatocyte growth factor-mediated uPA secretion by Hep-G2 cells is reduced with increasing concentrations of PD 098059 Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
HEP-3B cell
-
Homo sapiens
-
Hep-G2 cell
-
Homo sapiens
-